NCT05444283

Brief Summary

The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Sep 2021

Longer than P75 for all trials

Geographic Reach
1 country

10 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Sep 2021Dec 2026

Study Start

First participant enrolled

September 1, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 5, 2022

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

5.3 years

First QC Date

June 29, 2022

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine genetic etiology for Recurrent Pregnancy Loss

    The WGS tool will be used to analyze the POC sample and parental blood samples to determine the clinical reportable genetic cause for RPL

    5 years

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Couples who have had two or more previous pregnancy losses and have undiagnosed cause of recurrent pregnancy loss.

You may qualify if:

  • Women with loss of a current singleton pregnancy at \< 20 0/7 weeks gestation, documented by ultrasonography or histopathological examination
  • History of one or more prior pregnancy losses
  • Euploid current pregnancy confirmed by karyotype, microarray, or STORK (Short-read Transpore Rapid Karyotyping) sequencing Note: A limited number of aneuploid losses will be included as part of the pilot phase

You may not qualify if:

  • History of parental karyotype abnormalities
  • History of antiphospholipid antibody syndrome
  • Evidence of uncontrolled diabetes
  • Evidence of uncontrolled thyroid disease
  • History of autoimmune disease related to pregnancy loss (e.g., systemic lupus erythematosus, rheumatoid arthritis)
  • History of uterine anomalies
  • History of cervical insufficiency
  • Cohort B - Maternal Effect Gene Cohort
  • \- Women with a history of three or more pregnancy losses of unknown cause, with or without a liveborn child
  • \- Known etiology for pregnancy loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

University of Colorado

Aurora, Colorado, 80045, United States

RECRUITING

Yale University

New Haven, Connecticut, 06511, United States

RECRUITING

Northwestern University

Chicago, Illinois, 60611, United States

RECRUITING

University of Chicago

Chicago, Illinois, 60611, United States

ACTIVE NOT RECRUITING

Gaelle Massoud

Baltimore, Maryland, 21205, United States

RECRUITING

Wayne State University

Detroit, Michigan, 48201, United States

RECRUITING

Columbia University

New York, New York, 10032, United States

RECRUITING

Pennsylvania State University

Hershey, Pennsylvania, 17033, United States

RECRUITING

University of Texas at Austin

Austin, Texas, 78712, United States

RECRUITING

University of Texas at San Antonio

San Antonio, Texas, 78299, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Products of conception and blood or saliva of one or both biological parents

Central Study Contacts

Yong-Hui Jiang, MD, PhD

CONTACT

Heping Zhang, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2022

First Posted

July 5, 2022

Study Start

September 1, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations